BioCentury
ARTICLE | Company News

NaPro, Thomas Jefferson University deal

June 30, 2003 7:00 AM UTC

NPRO partnered with the university’s Jefferson Medical College and the Children’s Hospital of Philadelphia to develop NPRO’s ex vivo gene editing therapy to treat sickle cell disease. ...